Limula Biotech Company

Limula Biotech proposes an automated gene therapy manufacturing platform that operates at the patient bedside. This platform allows to automatically manufacture, from a patient white blood cell sample, genetically engineered cells at its bedside. Limula Biotech is building the first fully contained automated system for CGT manufacturing, allowingrapid and safe production of treatments directly at the patients beside. By enabling distributed manufacturing at the hospital, Limula’s technology will save time, cut costs, simplify logistics, and ultimately increase the safety and accessibility of these cutting edge personalized treatments.


Technology: Others
Industry: Gene Therapy
Headquarters: Vaud
Founded Date: 2018
Funding Status: Seed

Visit Website
Register and Claim Ownership